Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/
- Forums
- ASX - By Stock
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets...
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.72 |
Change
-0.150(0.72%) |
Mkt cap ! $2.648B |
Open | High | Low | Value | Volume |
$20.96 | $21.28 | $20.61 | $4.984M | 239.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 782 | $20.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.72 | 1021 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 782 | 20.610 |
2 | 3495 | 20.600 |
2 | 649 | 20.590 |
2 | 1774 | 20.570 |
1 | 145 | 20.550 |
Price($) | Vol. | No. |
---|---|---|
20.720 | 1021 | 2 |
20.730 | 5256 | 1 |
20.750 | 2517 | 1 |
20.790 | 782 | 1 |
20.800 | 649 | 2 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online